Email mark.jit@lshtm.ac.uk

Mark Jit is professor of vaccine epidemiology and head of the Department of Infectious Disease Epidemiology at the London School of Hygiene & Tropical Medicine (LSHTM). He also holds visiting professorial appointments at the NUS Saw Swee Hock School of Public Health and the School of Public Health, University of Hong Kong. His research group focuses on epidemiological and economic modelling of vaccines to support evidence-based public health decision making.

Mark has published over 250 papers covering a range of vaccine-preventable or potentially vaccine-preventable diseases including COVID-19, measles, HPV, pneumococcus, rotavirus, influenza, Group B Streptococcus, dengue, EV71 and RSV as well as methodological papers advancing the ways vaccines are evaluated. This work has influenced many of the major changes to immunisation policy globally.

He also organises or contributes to academic and professional courses on vaccine modelling, economics and decision science around the world. Since 2020, a major focus of his work has been on understanding the COVID-19 pandemic and ways to mitigate it.

• NUS Saw Swee Hock School of Public Health (Visiting)
• Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine (Primary)
• School of Public Health, University of Hong Kong (Visiting)

• Health decision science
• Infectious disease modelling
• Health economics
• Vaccination

• BSc in Mathematics (University College London)
• PhD in Mathematics (University College London)
• Master of Public Health (King’s College London

• Research fellow, University College London (2003-2005)
• Health economist (2006-2008), Senior infectious disease modeler (2009-2018) and Principal infectious disease modeler (2018-2020), Public Health England (formerly Health Protection Agency)
• Senior lecturer, University of Birmingham (2008-2009)
• Senior lecturer (2012-2015), Reader (2016) and Professor (2016-present), London School of Hygiene & Tropical Medicine

• Head, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine (2022 – present)
• Co-head, Modelling group, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine (2019 – 2022)

• Sandmann F, Davies NG, CMMID COVID-19 working group, Vassall A, Edmunds WJ, Jit M. The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: transmission model-based future scenario analysis and economic evaluation. Lancet Infectious Diseases 2021; 21(7):P962-74.
• Wouters OJ, Shadlen KC, Salcher-Konrad M, Pollard AJ, Larson HJ, Teerawattananon Y, Jit M. Global COVID-19 vaccine challenges: production, affordability, allocation, and deployment. Lancet 2021; 397(10278):1023-34.
• Russell TW, Wu JT, Clifford S, Edmunds WJ, Kucharski AJ, Jit M, CMMID COVID-19 Working Group. The effect of internationally imported cases on internal spread of COVID-19: a mathematical modelling study. Lancet Public Health 2020; 6(1):e12-e20.
• Chen C, Cervero Liceras F, Flasche S, Sidharta S, Yoong J, Sundaram N, Jit M. Effect and cost-effectiveness of pneumococcal conjugate vaccination: a global modelling analysis. Lancet Global Health 2019; 7(1):e58-e67.
• Atkins KE, Lafferty EI, Deeny SR, Davies NG, Robotham JV, Jit M. Use of mathematical modelling to assess the impact of vaccines on antibiotic resistance. Lancet Infect Dis. 2018 Jun;18(6):e204-e213. doi: 10.1016/S1473-3099(17)30478-4. Epub 2017 Nov 13. PMID: 29146178.
• Prem K, Cook AR, Jit M. Projecting social contact matrices in 152 countries using contact surveys and demographic data. PLoS Comput Biol. 2017 Sep 12;13(9):e1005697. doi: 10.1371/journal.pcbi.1005697. PMID: 28898249; PMCID: PMC5609774.
• Jit M, Brisson M, Portnoy A, Hutubessy R. Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study. Lancet Glob Health. 2014 Jul;2(7):e406-14. doi: 10.1016/S2214-109X(14)70237-2. Epub 2014 Jun 9. PMID: 25103394.
• Jit M, Choi YH, Edmunds WJ. Economic evaluation of human papillomavirus vaccination in the United Kingdom. BMJ. 2008 Jul 17;337:a769. doi: 10.1136/bmj.a769. PMID: 18640957; PMCID: PMC2500202.